Precision diagnosis and therapy for pediatric central nervous system tumors: consensus from the Brazilian Society of Pediatric Oncology (SOBOPE)
Open Access
- 2 March 2026
- journal article
- review article
- Published by Elsevier in The Lancet Regional Health - Americas
- Vol. 57, 101422
Abstract
No abstract availableKeywords
This publication has 59 references indexed in Scilit:
- Rayyan—a web and mobile app for systematic reviewsSystematic Reviews, 2016
- An integrative molecular and genomic analysis of pediatric hemispheric low-grade gliomas: an updateChild's Nervous System, 2016
- Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cellsDrug Design, Development and Therapy, 2016
- Cytogenetic Prognostication Within Medulloblastoma SubgroupsJournal of Clinical Oncology, 2014
- Assessing PIK3CA and PTEN in Early-Phase Trials with PI3K/AKT/mTOR InhibitorsCell Reports, 2014
- Paradoxical activation and RAF inhibitor resistance of BRAF protein kinase fusions characterizing pediatric astrocytomasProceedings of the National Academy of Sciences, 2013
- Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor responseProceedings of the National Academy of Sciences, 2012
- Primary Neurosurgery for Pediatric Low-Grade Gliomas: A Prospective Multi-Institutional Study From the Children's Oncology GroupNeurosurgery, 2011
- Evaluation status and prognostic significance of O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation in pediatric high grade gliomasChild's Nervous System, 2010
- Pediatric low-grade gliomas and the need for new options for therapy: why and how?Cancer Biology & Therapy, 2009